Collaboration Between Honeywell International Inc. and Bigfinite Inc. to Boost Digital Transformation with The Next-Generation Platforms for Pharmaceutical and Biotechnology Companies

Collaboration Between Honeywell International Inc. and Bigfinite Inc. to Boost Digital Transformation with The Next-Generation Platforms for Pharmaceutical and Biotechnology Companies

In February 2020, Honeywell International Inc., a technology company entered into a collaboration with Bigfinite Inc., a U.S. based company, with an aim of delivering advanced platforms and solutions for the life sciences industry. With the collaboration, the two companies will integrate Honeywell International Inc.’s deep knowledge in controls technology and process automation with Bigfinite Inc.’s data analytics, machine learning, and artificial intelligence platform, designed precisely for the pharmaceutical and biotechnology industries. In November 2019, the Honeywell Ventures had invested in Series-B Financing of Bigfinite, Inc.

Life sciences-focused offerings of Honeywell, powered by the Bigfinite platform, will improve manufacturing process operations and combine compliance-related manufacturing data enclosed in different systems across the enterprise into a single, visual interface for drug manufacturers. This will involve data from batch management, laboratory information management, control, manufacturing execution, quality management, and inventory systems. The objective is to allow more efficient audit-readiness and quicker delivery of medical therapies to the customers.

Together, Honeywell’s advanced process automation and visualization and Bigfinite’s cloud-based Software-as-a-Service (SaaS) platform offer real-time visibility and predictive insights through artificial intelligence, advanced analytics, and Internet-of-Things technologies with end-to-end data integrity. Moreover, through improved regulatory visibility, transparency, and digital transformation of manual procedures, the new solutions will permit life sciences companies to reduce the regulatory threat, surge operational efficiencies and faster delivery of products to customers while decreasing rejections and wastage of products.

Presently, the life sciences industry is at a crucial point in its history. The industry faces new challenges in getting treatments on the market while at the same time the industry has opportunities to utilize flourishing technologies such as artificial intelligence (AI) and machine learning to tackle challenges. But applying the advanced technologies to solve the problems is quite difficult. Honeywell International Inc. and Bigfinite Inc. have collaborated to assist their customers to figure it out.

Leave a Reply

Your email address will not be published. Required fields are marked *

SHARE YOUR CART